Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222430 · ClinicalTrials.gov registry record · NA
Fluoroscopy Guided Femoral Arterial Access
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 990
- Enrollment target
NCT00222430: Completed NA study, sponsored by University of Oklahoma.
NCT00222430 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 990 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00222430, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 990 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the use of fluoroscopic guidance, (a commonly used X-ray technique), with the traditional approach, (where the doctors feel for the strongest pulse), to obtain access to the blood vessel in the groin. These two methods are being compared to assess which is faster, safer and more often allows your physician to use an "arterial closure device," a small suture or plug applied at the end of the angiogram where the needle enters your blood vessel if he/she chooses.
Interventions
- PROCEDURE Fluoroscopy
- PROCEDURE Active Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 990 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-07 |
| Phase | NA |
What the finished NCT00222430 record still lists
NCT00222430 is an interventional study that assigns participants to a tested intervention. The registered 990 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 2 interventions - of which Fluoroscopy is the first listed.
NCT00222430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00222430 about?
NCT00222430 is a clinical study titled "Fluoroscopy Guided Femoral Arterial Access". The purpose of this study is to compare the use of fluoroscopic guidance, (a commonly used X-ray technique), with the traditional approach, (where the doctors feel for the strongest pulse), to obtain access to the blood vessel in the groin. These two methods are being compared to assess which is fas...
What is the current status of trial NCT00222430?
This trial is currently completed. It is a NA study. The enrollment target is 990 participants. The study started on 2005-03. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00222430?
The interventions under investigation include: Fluoroscopy (PROCEDURE), Active Comparator (PROCEDURE).
Who is sponsoring clinical trial NCT00222430?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00222430's enrollment target sits among peer trials
990 121st of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- NCT06883305 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia